(株)カイオム・バイオサイエンスの貸借残高情報

主市場業種証券コード/EDINET英名称
東証GRT医薬品4583/E26096Chiome Bioscience Inc.
公表日公表貸付残高前週比新規貸付成約高前週比借入残高前週比新規借入成約高前週比
2025/02/28日証協17,488,706株+4.11%1,772,068株-68.92%17,161,748株-5.86%1,590,102株-46.45%
2025/02/21日証協16,797,606株-23.28%5,701,304株+79.27%18,229,667株-10.83%2,969,512株+218.48%
2025/02/14日証協21,895,702株+0.13%3,180,300株-78.53%20,442,735株-9.74%932,401株-66.85%
2025/02/07日証協21,867,890株-5.76%14,815,548株+16.76%22,648,433株+5.2%2,812,605株+39.09%
2025/01/31日証協23,204,242株+18.22%12,688,769株+25.86%21,528,780株+0.21%2,022,102株-20.66%
2025/01/24日証協19,627,890株-9.11%10,082,000株+98.04%21,483,126株+4.73%2,548,510株-34.55%
2025/01/17日証協21,594,726株+36.83%5,091,016株-45.12%20,512,452株+8.32%3,894,003株+16.12%
2025/01/10日証協15,782,126株-2.53%9,277,476株+2879.28%18,937,550株+6.14%3,353,304株+190.38%
2024/12/30日証協16,191,584株-1.62%311,400株-95.31%17,842,728株-8.52%1,154,801株-73.45%
2024/12/27日証協16,458,284株+0.93%6,642,600株-37.25%19,504,728株+13.86%4,350,304株-4.15%
2024/12/20日証協16,306,784株-12.61%10,585,700株+87.53%17,130,225株-5.48%4,538,638株+12.97%
2024/12/13日証協18,660,784株+15.68%5,644,700株-51.31%18,124,077株+15.35%4,017,416株-38.09%
2024/12/06日証協16,131,484株+16.48%11,592,400株+116.95%15,711,871株+10.75%6,489,516株+42.76%
2024/11/29日証協13,848,784株-11.39%5,343,462株+15.93%14,186,172株+1.44%4,545,602株+123.28%
2024/11/22日証協15,629,154株+2.65%4,609,132株+62.17%13,984,655株+0.12%2,035,815株+486.86%
2024/11/15日証協15,225,954株-1.66%2,842,100株+48.69%13,968,355株-3.62%346,900株-5.66%
2024/11/08日証協15,482,354株+16.85%1,911,416株-54.48%14,493,655株+2.52%367,700株-57.71%
2024/11/01日証協13,249,638株-9.17%4,199,090株+28%14,137,355株+2.81%869,449株+166.22%
2024/10/25日証協14,587,028株+0.8%3,280,600株-8.32%13,750,596株+1.19%326,590株-54.91%

※株式分割は考慮していませんのでご注意ください。

Page Top